title: A race for an Ebola vaccine: promises and obstacles.
abstract: While several impeding factors have limited Ebola vaccine development, the current epidemic has provided a surge which may lead to a record pace for a vaccine against Ebola. Consequently, multiple FDA trials are currently underway using two promising vaccine platforms; one has recently demonstrated durable immunity within non-human primates.
authors.affiliation: Molecular and Translational Sciences, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
authors.forename: Christopher L
authors.initials: CL
authors.lastname: Cooper
authors.affiliation: Molecular and Translational Sciences, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA. Electronic address: sina.bavari.civ@mail.mil.
authors.forename: Sina
authors.initials: S
authors.lastname: Bavari
mesh_terms: D000818:Animals; D046129:Ebola Vaccines / Q000276:immunology / Q000627:therapeutic use; D019142:Hemorrhagic Fever, Ebola / Q000517:prevention & control*; D006801:Humans; D011323:Primates
chemical_list: D046129:Ebola Vaccines
keywords: Ebola; FDA clinical trial; durable immunity; immune correlates; vaccine